Tag: Robust antimicrobial resistance surveillance needed in SEA

Robust antimicrobial resistance surveillance needed in SEA

October 7, 2019

A particular resistance to two kinds of drugs, namely carbapenems and polymyxins, in Southeast Asia (SEA) has prompted the World Health Organisation (WHO) and the US Centers for Disease Control and Prevention (CDC) to evaluate their clinical risks to the masses before it becomes a widespread threat. Carbapenems and polymyxins can potentially spread “mobile genetic […]

Continue Reading